A quantitative cell-ELISA for α-galactose specific antibodies in human malaria

Journal of Immunoassay

Volumn 17, Issue 3, 1996, Pages 245-256

  Satapathy, Ashok K ^a   Ravindran, B ^a  

^a REGIONAL MEDICAL RESEARCH CENTRE ICMR   (India)

Author keywords

Anti gal; antibody; Auto; Cell ELISA; Immunoassay; Malaria

Indexed keywords

AUTOANTIBODY; GALACTOSE; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANTIBODY DETECTION; ARTICLE; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; HUMAN; MALARIA; NONHUMAN;

EID: 0029821312     PISSN: 01971522     EISSN: None     Source Type: Journal    
DOI: 10.1080/01971529608005791     Document Type: Article

References (14)

1. Galili, U., Rachmilewitz, E.A., Peleg, A. and Flechner, I. A unique natural human IgG antibody with anti-α-galactosyl specificity. J. Exp. Med. 1984; 160: 1519-31.
2. Galili, U., Macher, B.A., Buehler, J. and Shohet, S.B. Human natural anti-a-galactosyl IgG. ii. The specific recognition of α(1-3) linked galactose residues. J. Exp. Med. 1985; 162: 573-82.
3. Avila, J.L., Rojas, M. and Galili, U. Immunogenic Gal α1-3 Gal carbohydrate epitopes are present on pathogenic American Trypanosoma and Leishmania. J. Immunol. 1989; 142:2828-34.
4. Towbin, H., Rosenfelder, G., Weislander, J., et al. Circulating antibodies to mouse laminin in chagas disease, American cutaneous leishmaniasis and normal individuals recognize terminal galactosyl (α 1-3) galactose epitopes. J. Exp. Med. 1987; 166: 419-32.
5. Ravindran, B., Satapathy, A.K. and Das, M.K. Naturally occurring anti-α-galactosyl antibodies in human Plasmodium falciparum infections: a possible role for autoantibodies in malaria, Immunol Lett.1988;19:137-42.
6. Malaise, M.G., Davin, J.C., Mahieu, P.R. and Franchimont, P. Elevated anti-galactosyl antibody titres reflect renal injury after Gold or D-pencillamine in Rheumatoid Arthritis. Clin, Immunol. Immunopathol. 1986; 40:356-64.
7. Galili, U., Clark, M.R. and Shohet, S.B. Excessive binding of the natural anti-α-galactosyl Ig G to sickle red cells may contribute to extravascular cell destruction. J. Clin. Invest. 1986; 77:27-33.
8. Etienne-Decerf, J., Malaise, P., Mahieu, M. and Winand, R. Elevated anti-α-galactosyl titre. A marker of progression in autoimmune thyroid disorders and in endocrine ophthalmology? Acta Endocrinologica. 1987; 115:67-74.
9. Galili, U., Mandrell, R.E., Hamadeh, R.M., Shohet. S.B. and Griffis, J.M. Interaction between human natural anti-α-galactosyl immunoglobulin G and bacteria of the human flora. Infect Immun. 1988; 57: 1730-7.
10. Galili, U., Bushler, IJ., Shohet, S.B. and Macher, B.A. The human natural anti-gal IgG III. The subtlety of immune tolerance in man as demonstrated by cross-reactivity between natural anti-gal and anti-B antibodies. J. Exp. Med. 1987; 165:693-704.
11. Galili, U., Anaraki, F., Thall, A., Hill-Black, C. and Radic, M. One percent of human circulating B lymphocytes are capable of producing the natural anti-gal antibody. Blood 1993; 82:2485-93.
12. Gabrielli, A., Leoni, P., Davieli, G., Herrmann, K., Krieg, T. and Wieslander, J. Antibodies against galactosyl α(1-3) galactose in connective tissue diseases. Arthritis Rheum. 1991; 34:375.
13. Mahieu, P. Anti-α-galactosyl antibodies and immune complexes in children with Henoch-Schonlein Purpura or IgA nephropathy. Kidney Int. 1987; 31:1132-9.
14. Galili, U. Evolution and pathophysiology of the human natural anti-α-galactosyl IgG (anti-gal) antibody. Springer Semin Immunopathol. 1993; 15:155-71.